| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.11 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |